Stay updated on Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page.

Latest updates to the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a small release update applied to the page’s underlying platform.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page revision line was updated from v3.6.2 to v3.6.3, indicating a small metadata update to the page without changes to the study information.SummaryDifference0.1%

- Check30 days agoChange DetectedThe study record revision was updated from v3.6.0 to v3.6.2, indicating a newer version of the documentation. This update appears administrative rather than affecting the study details.SummaryDifference0.1%

- Check44 days agoChange DetectedEnrollment status updated to no longer recruit participants, and new sections including How to Read a Study Record, Common Questions, How to Join a Study, and the Intervention/Treatment area were added, along with a revision notice (Revision: v3.6.0).SummaryDifference0.4%

- Check51 days agoChange DetectedThe page revision label was updated to v3.5.5, replacing the previous v3.5.4; this appears to be a metadata update rather than a substantive change to the study details.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page now shows Revision: v3.5.4 as the current version, replacing the previous v3.5.3.SummaryDifference0.1%

Stay in the know with updates to Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page.